Aston Sci. Inc., a clinical-stage biopharmaceutical company pioneering next-generation therapeutic cancer vaccines, announced ...

The discovery could pave the way for new treatments, improved risk prediction, and earlier intervention for brain metastases.

The FDA-approved drug combination specifically targets low-grade serous ovarian cancer, which primarily affects younger women ...

A team of Australian researchers have developed a new targeted therapeutic approach that could improve treatment for ...

Scientists at St. Jude Children's Research Hospital have revealed previously unappreciated roles for the retrotransposon LINE ...

University of Manchester researchers have shown that analysis of fluid flushed through a fallopian tube holds promise for ...

Global cancer cases have surged dramatically, doubling since 1990 and reaching 18.5 million new diagnoses in 2023. Deaths ...

Genmab will stop development of its experimental antibody therapy to treat cancer that was in late-stage trials, the ‍Danish drugmaker said on Monday. The company had assumed sole responsibility for ...

The decision to end the programme comes 18 months after Genmab's former partner for the acasunlimab, BioNTech, pulled out of ...

Scientists have presented a new approach to cancer treatment using mast cells, which are immune cells known for their ability ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. On the regional level, as the Human Development Index ...

Cancer is a disease that starts with uncontrolled cell division and eventually causes tissue and organ damage. The disease ...